Abdominal Imaging in Persistent Reflux Symptoms on PPI Therapy
In this 78-year-old patient with persistent reflux symptoms and constipation despite omeprazole therapy, abdominal CT is indicated to exclude gastric malignancy and evaluate for complications, particularly given the patient's age and suboptimal response to PPI treatment.
Primary Indication: Rule Out Gastric Malignancy
The FDA label for omeprazole explicitly warns that symptomatic response does not preclude gastric malignancy, and specifically recommends considering additional diagnostic testing in older patients who have suboptimal response to PPI therapy, including endoscopy. 1
In patients with persistent symptoms despite PPI treatment, additional follow-up and diagnostic testing is mandated to exclude underlying malignancy, with particular emphasis on older patients. 1
The combination of advanced age (78 years), persistent symptoms on standard PPI therapy, and the presence of constipation (which could indicate mass effect or obstruction) creates a clinical scenario requiring imaging evaluation.
Role of CT Abdomen in This Clinical Context
CT abdomen is appropriate as an initial diagnostic test when patients present with nonspecific or overlapping symptoms, even though it is not the primary test for uncomplicated GERD. 2
CT can identify gastric or duodenal wall thickening, mucosal hyperenhancement, fat stranding, focal outpouching from ulcerations, or signs of gastric outlet obstruction—all findings that could explain persistent symptoms. 2
In peptic ulcer disease (PUD), CT demonstrates high sensitivity (95%) and specificity (93%) for localization of perforation sites when wall defects and wall thickening are present together. 2
CT findings suggestive of gastritis or PUD include: gastric/duodenal wall thickening (≥5mm), submucosal edema, mucosal hyperenhancement, fluid along the gastroduodenal region, or focal perforation with free air. 2
Why Not Ultrasound Alone
The ACR Appropriateness Criteria for epigastric pain do not prioritize ultrasound for evaluating suspected upper GI pathology, reflux complications, or gastric malignancy. 2
Ultrasound has limited utility for evaluating the stomach, duodenum, and esophagus compared to CT, particularly in elderly patients where bowel gas and body habitus may limit visualization.
Clinical Context Supporting Imaging
Approximately 19% of patients on omeprazole 20 mg twice daily demonstrate persistent abnormal gastric acid secretion, suggesting that treatment failure is not uncommon and warrants investigation. 3
While omeprazole effectively reduces acid reflux episodes, it does not reduce the total number of reflux episodes—it simply converts acid reflux to less acidic reflux. 4
The persistence of symptoms on standard-dose PPI therapy (20 mg daily) in this patient suggests either inadequate acid suppression, non-acid reflux, or an alternative diagnosis requiring investigation. 3, 4
Additional Considerations
The constipation component should not be overlooked, as it could represent:
- Mass effect from gastric or colonic pathology
- Medication side effect from docusate alone being insufficient
- Part of a broader intra-abdominal process
Common pitfalls to avoid:
- Do not assume persistent symptoms on PPI therapy are simply refractory GERD without excluding structural pathology or malignancy, especially in elderly patients. 1
- Do not continue escalating PPI doses without objective evaluation in older patients with alarm features or treatment failure. 1
- The FDA specifically warns about the risk of C. difficile-associated diarrhea with PPI use, though this patient has constipation rather than diarrhea. 1
Recommended Approach
Order CT abdomen and pelvis with oral and IV contrast to evaluate for:
- Gastric mass or malignancy
- Gastric outlet obstruction
- Peptic ulcer disease or perforation
- Colonic pathology explaining constipation
- Other intra-abdominal pathology
Following CT results, consider upper endoscopy as the definitive test for mucosal evaluation and tissue diagnosis if CT shows concerning findings or is unrevealing but symptoms persist. 1